The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
7 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,950,581 in first-year total cost, median $419,375.
Most frequent study sections
- Special Emphasis Panel[ZTR1 DPI-7 (03)]7
Most frequent institutions
- UNIVERSITY OF FLORIDA2
- DUKE UNIVERSITY1
- FLORIDA ATLANTIC UNIVERSITY1
- FLORIDA INTERNATIONAL UNIVERSITY1
- STANFORD UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2024 | Exploring the unknown function of LRRC55 in pain1R21NS136065-01 | CHEN, YONGYANG, HUANGHE | DUKE UNIVERSITY, NC | $444,125 | ZTR1 |
| 2024 | Binding NF-κB essential modulator (NEMO) to Treat Surgical Pain1R21AG086147-01 | GROSS, ERIC RICHARD | STANFORD UNIVERSITY, CA | $427,187 | ZTR1 |
| 2024 | Targeting GTP Cyclohydrolase 1 for treating chronic orofacial pain1R21DE033640-01 | AYAZ, BASAKMURPHY, NIALL P | UNIVERSITY OF FLORIDA, FL | $419,375 | ZTR1 |
| 2024 | Role of Understudied aGPCRs in Orofacial Neuropathic Pain1R21DE033639-01 | AYAZ, BASAKCAUDLE, ROBERT M | UNIVERSITY OF FLORIDA, FL | $419,375 | ZTR1 |
| 2024 | The involvement of GPR37L1 on a chronic migraine-like state1R21NS136077-01 | CIPPITELLI, ANDREAROBISHAW, JANET D | FLORIDA ATLANTIC UNIVERSITY, FL | $419,375 | ZTR1 |
| 2024 | Role of Scn1b in Susceptibility to Neuropathic Pain1R21NS136075-01 | BAUTISTA, DIANA MICHELELUMPKIN, ELLEN A | UNIVERSITY OF CALIFORNIA BERKELEY, CA | $415,519 | ZTR1 |
| 2024 | The potential benefits of autophagy activator TFEB in opioid use disorder in mice1R21DA060111-01 | LAKSHMANA, MADEPALLI KRISHNAPPA | FLORIDA INTERNATIONAL UNIVERSITY, FL | $405,625 | ZTR1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.